Countries
Institutions
Fields
Rankings
Compare

Search institutions, scholars, countries and publications

Sankore

Named after the University of Sankore in Timbuktu — one of the world’s oldest centres of learning. Every figure here is computed from work-level records in our own graph, never copied from a source’s summary count.

Built from

OpenAlex — works, authorships, subject classification
ROR — institutional identity
ORCID — researcher identity
Crossref — publisher confirmation

Browse

Countries
Institutions
Fields
Rankings
What we cover

Coverage is partial and says so. A country appears with its research output only once its works have been swept; until then the portal shows whatever the graph happens to hold for it and labels it as exactly that.

Korupensamine A, but not its atropisomer, korupensamine B, inhibits SARS-CoV-2 in vitro by targeting its main protease (Mpro)

2023European Journal of Medicinal ChemistryJournalOpen access

10.1016/j.ejmech.2023.115226 Full text13 citations

Authors

9 authors across 6 institutions in 3 countries.

Ahmed M. SayedFirst author
- Nahda University (EG)
Alyaa Hatem Ibrahim
- Sohag University (EG)
Nasir Tajuddeen
- Ahmadu Bello University (NG)
Jürgen Seibel
Jochen Bodem
Nina Geiger
Kathrin Striffler
Gerhard BringmannCorresponding
Usama Ramadan AbdelmohsenSenior authorCorresponding
- Deraya University (EG)
- Minia University (EG)

Fields

Assignment is probabilistic — a work belongs to several fields in proportions.

Axial and Atropisomeric Chirality Synthesislevel 3 · 1.00
Sphingolipid Metabolism and Signalinglevel 3 · 1.00
Mathematical and Theoretical Epidemiology and Ecology Modelslevel 3 · 0.98

Sources

Several sources describing one work is the point — it means the record rests on more than one authority.

openalexseen September 9, 2026
2023 · European Journal of Medicinal Chemistry · 13 citations
https://openalex.org/W4322627103

Korupensamine A, but not its atropisomer, korupensamine B, inhibits SARS-CoV-2 in vitro by targeting its main protease (Mpro) · Sankore